fatty liver disease Companies
-
based in Loos, FRANCE
GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases. Our translational disease-driven research approach is based on strong expertise, featuring in-house knowledge of ...
GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases. Our translational disease-driven research approach is based on strong expertise, featuring in-house knowledge of ...
-
based in Ann Arbor, MICHIGAN (USA)
ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS) platform to enable clinicians to visualize human tissue composition, function and ...
ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS) platform to enable clinicians to visualize human tissue composition, function and ...
-
based in Montreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
-
based in Rochester, MINNESOTA (USA)
Resoundant, Inc. is a medical technology company founded by Mayo Foundation for Medical Education and Research and is located in Rochester, MN. Resoundant is dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance ...
Resoundant - Magnetic Resonance Elastography (MRE) Medical Imaging Software
expensive alternative to needle biopsy for liver fibrosis ...
REQUEST QUOTEResoundant, Inc. is a medical technology company founded by Mayo Foundation for Medical Education and Research and is located in Rochester, MN. Resoundant is dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance ...
-
based in Vancouver, BRITISH COLUMBIA (CANADA)
Sonic Incytes is redefining the standard of care in quantifying liver stiffness and attenuation. Recognizing the rise of fatty liver disease, we’ve made it our mission to make liver health a new vital sign. Our novel, portable, handheld solution ...
Sonic Incytes is redefining the standard of care in quantifying liver stiffness and attenuation. Recognizing the rise of fatty liver disease, we’ve made it our mission to make liver health a new vital sign. Our novel, portable, handheld solution ...
-
based in Schlieren, SWITZERLAND
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...
InSphero 3D InSight - Model Steatosis - Advanced Human Disease
The 3D InSight™ Steatosis Model is an advanced human disease model that enables you to screen compounds and investigate disease pathophysiology using a physiologically relevant human liver ...
REQUEST QUOTEInSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...
-
based in Gaithersburg, MARYLAND (USA)
Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide, is a GLP-1/glucagon dual ...
Model ALT-801 - Dual GLP-1/Glucagon Agonist For NASH
A peptide-based dual GLP-1/glucagon receptor agonist designed to treat the metabolic dysfunction that causes non-alcoholic steatohepatitis (NASH). NASH, the most severe form of non-alcoholic fatty liver ...
REQUEST QUOTEAltimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide, is a GLP-1/glucagon dual ...
-
based in Sint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
Liver Disease (Nash) and Ascites
Liver disease, a large and growing market globally. Cirrhosis is late-stage liver disease which occurs when scar tissue (fibrosis) replaces healthy tissue. Alcohol and viral ...
REQUEST QUOTEWe are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
-
based in Buk-gu, SOUTH KOREA
JD Bioscience (JDB) is a group of experts in small molecule-based novel drug development. JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases. ...
JDB - Non-Alcoholic Steatohepatitis (NASH)
NASH, an advanced form of non-alcoholic fatty liver disease (NAFLD), can progress to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Genetic factors, environmental ...
REQUEST QUOTEJD Bioscience (JDB) is a group of experts in small molecule-based novel drug development. JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases. ...
-
based in Midlothian, VIRGINIA (USA)
G3T is developing assets in cardio-metabolic, metabolic and cardiovascular diseases, such as non-alcoholic steatohepatitis (NASH), obesity, diabetes, atherosclerosis, etc. We define our assets as genetically validated drug targets. We partner with ...
G3T - Pharmaceutical Pipeline
All drugs targeting cardiovascular disease currently on the market work by lowering cholesterol levels. G3T identified and genetically validated an entirely novel biological mechanism and potential drug target that treats both ...
REQUEST QUOTEG3T is developing assets in cardio-metabolic, metabolic and cardiovascular diseases, such as non-alcoholic steatohepatitis (NASH), obesity, diabetes, atherosclerosis, etc. We define our assets as genetically validated drug targets. We partner with ...
-
based in Logan, UTAH (USA)
Our teams build and develop customizable multiplex and singleplex assay technologies that allow pharmaceutical companies, clinical laboratories, government institutions, universities, and academics around the world access to large amounts of ...
Q-Plex - Model GBP-28, apM1, AdipoQ, Acrp30 - Human Adiponectin Analyte
is produced by adipose tissue in bone marrow. Decreased adiponectin levels are associated with metabolic disorders, including non-alcoholic fatty liver disease, obesity, type 2 diabetes, insulin ...
REQUEST QUOTEOur teams build and develop customizable multiplex and singleplex assay technologies that allow pharmaceutical companies, clinical laboratories, government institutions, universities, and academics around the world access to large amounts of ...
-
based in Aberdeen, HONG KONG
Over the last 10 years, Creative Biolabs has become a leader of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world. Creative Biolabs was founded by ...
Nutritional Models of NAFLD/NASH
Nonalcoholic fatty liver disease (NAFLD), one of the most common chronic liver disease, is a condition characterized by abnormal excessive fat accumulation in the ...
REQUEST QUOTEOver the last 10 years, Creative Biolabs has become a leader of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world. Creative Biolabs was founded by ...
-
based in Merion, PENNSYLVANIA (USA)
Glycotest is a liver disease diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis. Founded in 2012 by NetScientific plc on technology originating at the Baruch S. Blumberg ...
Glycotest Technology
Glycotest blood tests are being developed to provide information on the likelihood of serious liver disease like cancer or fibrosis-cirrhosis by employing technology designed to measure two kinds of ...
REQUEST QUOTEGlycotest is a liver disease diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis. Founded in 2012 by NetScientific plc on technology originating at the Baruch S. Blumberg ...
-
based in Menlo Park, CALIFORNIA (USA)
CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to ...
CohBar - Model CB4211 - Biotechnology for Nonalcoholic Steatohepatitis (NASH) and Obesity
in multiple preclinical models. Has been shown in a clinical study to significantly reduce ALT and AST, key biomarkers of liver damage, as well as glucose levels compared to placebo. Resulted in a trend towards lower body weight ...
REQUEST QUOTECohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to ...
-
based in San Antonio, TEXAS (USA)
BioMedSA was founded in 2005 to accelerate growth of the healthcare and bioscience sector, create regional economic benefit, and contribute to the health of San Antonio and beyond by establishing San Antonio as a leader in healthcare and bioscience. ...
Testing Services
Pre-clinical studies are conducted in San Antonio using a variety of animal models. The Southwest National Primate Research Center at the Texas Biomedical Research Institute houses over 2,500 nonhuman primates including over 1,000 baboons, making it ...
REQUEST QUOTEBioMedSA was founded in 2005 to accelerate growth of the healthcare and bioscience sector, create regional economic benefit, and contribute to the health of San Antonio and beyond by establishing San Antonio as a leader in healthcare and bioscience. ...
-
based in Tübingen, GERMANY
HepaRegeniX GmbH is a clinical stage company developing novel therapies for the treatment of acute and chronic liver diseases. Since its start in 2017, HepaRegeniX has successfully discovered and developed several drug candidates for the treatment ...
HepaRegeniX - Liver Diseases Face an Enormous Unmet Medical Need
Liver diseases are characterized by a gradual deterioration of the liver function, and, on a molecular level, by a reorganization and destruction of liver tissue. Several ...
REQUEST QUOTEHepaRegeniX GmbH is a clinical stage company developing novel therapies for the treatment of acute and chronic liver diseases. Since its start in 2017, HepaRegeniX has successfully discovered and developed several drug candidates for the treatment ...
-
based in London, UNITED KINGDOM
Multiomic Health Limited is a next-generation precision medicine business, applying computational systems biology to develop and commercialize data assets for metabolic syndrome. Multiomic is a next-generation precision medicine business, applying ...
Multiomic Health Limited is a next-generation precision medicine business, applying computational systems biology to develop and commercialize data assets for metabolic syndrome. Multiomic is a next-generation precision medicine business, applying ...
-
based in Deventer, NETHERLANDS
From its location in the Netherlands, Kepro has been producing veterinary pharmaceuticals for livestock since 1972. Our products can be found in 85 countries worldwide, from Europe, Africa, the Middle East and Asia to Central and South America. We ...
From its location in the Netherlands, Kepro has been producing veterinary pharmaceuticals for livestock since 1972. Our products can be found in 85 countries worldwide, from Europe, Africa, the Middle East and Asia to Central and South America. We ...
-
based in Dwarka, INDIA
Everflow Global. We are a leading company engaged in water & air treatment using the bioremediation Process. We offer you the best technology in industrial wastewater treatment. Our cleantech solutions are focused on Carbon negative and ...
Everflow - Astaxanthin Powder
applications in Alzheimer’s disease, muscle improvements for athletics, and skin rejuvenation. Its market demand and commercial importance are high due to its applications in dietary supplements for humans, animals, and ...
REQUEST QUOTEEverflow Global. We are a leading company engaged in water & air treatment using the bioremediation Process. We offer you the best technology in industrial wastewater treatment. Our cleantech solutions are focused on Carbon negative and ...
-
based in Yunchengxi Baiyun, CHINA
DUTTO PHARMACEUTICAL Company, founded in 1998, is a comprehensive modernized veterinary drugs hi-tech enterprise integrating R&D, production, sales and service. For decades, the company is the pioneer devoting to providing overall solutions on ...
DUTTO PHARMACEUTICAL Company, founded in 1998, is a comprehensive modernized veterinary drugs hi-tech enterprise integrating R&D, production, sales and service. For decades, the company is the pioneer devoting to providing overall solutions on ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you